Campo pioneered research in this field, discovering in the early 1930s that a class of peptides called 'incretins' could promote - cells' insulin release, promoting blood-sugar metabolism, appetite regulation, and subsequent weight loss
Abstract Background Cognitive function can be affected in conditions with raised intracranial pressure (ICP) such as idiopathic intracranial hypertension (IIH)
Individual weight loss results vary and depend on medication adherence, diet, exercise, and individual metabolic factors
The severity of these conditions and increasing news coverage has driven rapid growth in the MDL, with more than 100 new lawsuits filed in October 2025 alone
BioSupply Trends Quarterly
We have already helped over 30,000 patients achieve safe and successful metabolic changes